Literature DB >> 18467168

Pathophysiology of parkinsonism.

Adriana Galvan1, Thomas Wichmann.   

Abstract

The motor signs of Parkinson's disease are thought to result in large part from a reduction of the level of dopamine in the basal ganglia. Over the last few years, many of the functional and anatomical consequences of dopamine loss in these structures have been identified, both in the basal ganglia and in related areas in thalamus and cortex. This knowledge has contributed significantly to our understanding of the link between the degeneration of dopamine neurons in the midbrain and the development of parkinsonism. This review discusses the evidence that implicates electrophysiologic changes (including altered discharge rates, increased incidence of burst firing, interneuronal synchrony, oscillatory activity, and altered sensorimotor processing) in basal ganglia, thalamus, and cortex, in parkinsonism. From these studies, parkinsonism emerges as a complex network disorder, in which abnormal activity in groups of neurons in the basal ganglia strongly affects the excitability, oscillatory activity, synchrony and sensory responses of areas of the cerebral cortex that are involved in the planning and execution of movement, as well as in executive, limbic or sensory functions. Detailed knowledge of these changes will help us to develop more effective and specific symptomatic treatments for patients with Parkinson's disease.

Entities:  

Mesh:

Year:  2008        PMID: 18467168      PMCID: PMC2467461          DOI: 10.1016/j.clinph.2008.03.017

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  219 in total

1.  GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation.

Authors:  R Betarbet; R H Porter; J T Greenamyre
Journal:  J Neurochem       Date:  2000-03       Impact factor: 5.372

2.  Activity patterns in a model for the subthalamopallidal network of the basal ganglia.

Authors:  D Terman; J E Rubin; A C Yew; C J Wilson
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

3.  Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats.

Authors:  M S Aymerich; P Barroso-Chinea; M Pérez-Manso; A M Muñoz-Patiño; M Moreno-Igoa; T González-Hernández; J L Lanciego
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

4.  Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.

Authors:  Zhongfeng Wang; Li Kai; Michelle Day; Jennifer Ronesi; Henry H Yin; Jun Ding; Tatiana Tkatch; David M Lovinger; D James Surmeier
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

5.  Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease.

Authors:  Andrea A Kühn; Andreas Kupsch; Gerd-Helge Schneider; Peter Brown
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

6.  The pedunculopontine and peripeduncular nuclei: a tale of two structures.

Authors:  Ludvic Zrinzo; Laurence V Zrinzo; Marwan Hariz
Journal:  Brain       Date:  2007-06       Impact factor: 13.501

7.  Comparative Ultrastructural Analysis of D1 and D5 Dopamine Receptor Distribution in the Substantia Nigra and Globus Pallidus of Monkeys.

Authors:  Michele A Kliem; Jean-Francois Pare; Zafar U Khan; Thomas Wichmann; Yoland Smith
Journal:  Adv Behav Biol       Date:  2009-08-21

Review 8.  Oscillations in the basal ganglia under normal conditions and in movement disorders.

Authors:  Plamen Gatev; Olivier Darbin; Thomas Wichmann
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

9.  Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease.

Authors:  Lars Timmermann; Lars Wojtecki; Joachim Gross; Ralph Lehrke; Jürgen Voges; Mohammed Maarouf; Harald Treuer; Volker Sturm; Alfons Schnitzler
Journal:  Mov Disord       Date:  2004-11       Impact factor: 10.338

10.  Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.

Authors:  A Priori; G Foffani; A Pesenti; F Tamma; A M Bianchi; M Pellegrini; M Locatelli; K A Moxon; R M Villani
Journal:  Exp Neurol       Date:  2004-10       Impact factor: 5.330

View more
  136 in total

1.  Changing views of basal ganglia circuits and circuit disorders.

Authors:  Mahlon DeLong; Thomas Wichmann
Journal:  Clin EEG Neurosci       Date:  2010-04       Impact factor: 1.843

2.  Influence of phasic and tonic dopamine release on receptor activation.

Authors:  Jakob K Dreyer; Kjartan F Herrik; Rune W Berg; Jørn D Hounsgaard
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

Review 3.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

4.  Bursts and oscillations as independent properties of neural activity in the parkinsonian globus pallidus internus.

Authors:  Vanessa Chan; Philip A Starr; Robert S Turner
Journal:  Neurobiol Dis       Date:  2010-08-19       Impact factor: 5.996

5.  Neuronal Entropy-Rate Feature of Entopeduncular Nucleus in Rat Model of Parkinson's Disease.

Authors:  Olivier Darbin; Xingxing Jin; Christof Von Wrangel; Kerstin Schwabe; Atsushi Nambu; Dean K Naritoku; Joachim K Krauss; Mesbah Alam
Journal:  Int J Neural Syst       Date:  2015-10-06       Impact factor: 5.866

6.  Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.

Authors:  Jonathan Chetrit; Anne Taupignon; Lionel Froux; Stephanie Morin; Rabia Bouali-Benazzouz; Frédéric Naudet; Nabila Kadiri; Christian E Gross; Bernard Bioulac; Abdelhamid Benazzouz
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

7.  Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.

Authors:  Christian Pifl; Stephen J Kish; Oleh Hornykiewicz
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

8.  Effects of stimulation of the centromedian nucleus of the thalamus on the activity of striatal cells in awake rhesus monkeys.

Authors:  Bijli Nanda; Adriana Galvan; Yoland Smith; Thomas Wichmann
Journal:  Eur J Neurosci       Date:  2009-01-17       Impact factor: 3.386

9.  Control of aperture closure initiation during reach-to-grasp movements under manipulations of visual feedback and trunk involvement in Parkinson's disease.

Authors:  Miya Kato Rand; Martin Lemay; Linda M Squire; Yury P Shimansky; George E Stelmach
Journal:  Exp Brain Res       Date:  2009-11-10       Impact factor: 1.972

10.  Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.

Authors:  Orhan Tansel Korkmaz; Neşe Tunçel; Muzaffer Tunçel; Elif Mine Oncü; Varol Sahintürk; Mustafa Celik
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.